{"id":"https://openalex.org/W2004252407","doi":"https://doi.org/10.4088/jcp.v66n0613","title":"Switching Outpatients With Bipolar or Schizoaffective Disorders and Substance Abuse From Their Current Antipsychotic to Aripiprazole","display_name":"Switching Outpatients With Bipolar or Schizoaffective Disorders and Substance Abuse From Their Current Antipsychotic to Aripiprazole","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-15","ids":{"openalex":"https://openalex.org/W2004252407","doi":"https://doi.org/10.4088/jcp.v66n0613","mag":"2004252407","pmid":"https://pubmed.ncbi.nlm.nih.gov/15960570"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v66n0613","doi":"https://doi.org/10.4088/jcp.v66n0613","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v66n0613","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004252407"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075547679","display_name":"E. Sherwood Brown","orcid":"https://orcid.org/0000-0002-8401-3743","observed_orcids":["https://orcid.org/0000-0002-8401-3743"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Sherwood Brown","raw_affiliation_strings":["Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, 75390, USA. Sherwood.Brown@UTSouthwestern.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, 75390, USA. Sherwood.Brown@UTSouthwestern.edu","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084343783","display_name":"Jala Jeffress","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jala Jeffress","raw_affiliation_strings":["University of Texas, Southwestern Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, Southwestern Medical Center","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006012733","display_name":"Joshua D.M. Liggin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joshua D. M. Liggin","raw_affiliation_strings":["University of Texas, Southwestern Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, Southwestern Medical Center","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081487704","display_name":"Monica J. Garza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Monica Garza","raw_affiliation_strings":["University of Texas, Southwestern Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, Southwestern Medical Center","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":null,"display_name":"Laura Beard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Beard","raw_affiliation_strings":["University of Texas, Southwestern Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas, Southwestern Medical Center","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I867280407"],"apc_list":null,"apc_paid":null,"fwci":5.3102,"has_fulltext":false,"cited_by_count":123,"citation_normalized_percentile":{"value":0.95795319,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"66","issue":"06","first_page":"756","last_page":"760"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.026499999687075615,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":1.0},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9810000061988831},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":1.0},{"id":"https://openalex.org/keywords/substance-abuse","display_name":"substance abuse","score":0.8700000047683716},{"id":"https://openalex.org/keywords/dual-diagnosis","display_name":"dual diagnosis","score":0.8320000171661377},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.8529999852180481},{"id":"https://openalex.org/keywords/alcohol-craving","display_name":"alcohol craving","score":0.8130000233650208},{"id":"https://openalex.org/keywords/cocaine-craving","display_name":"cocaine craving","score":0.9890000224113464},{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.8489999771118164},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.6840000152587891},{"id":"https://openalex.org/keywords/mania","display_name":"mania","score":0.6420000195503235},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6480000019073486},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8080000281333923},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C2777089681","wikidata":"https://www.wikidata.org/wiki/Q4340609","display_name":"Young Mania Rating Scale","level":5,"score":0.8084076642990112},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.6982353925704956},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.6493326425552368},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5790524482727051},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.5597178339958191},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5538102388381958},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.550675094127655},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.49024897813796997},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.48876333236694336},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.4632149338722229},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.46003374457359314},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3740602433681488},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.2011418342590332},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.197109192609787},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.18714779615402222}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D017831","descriptor_name":"Diagnosis, Dual (Psychiatry)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v66n0613","doi":"https://doi.org/10.4088/jcp.v66n0613","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v66n0613","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:15960570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15960570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1571292605","https://openalex.org/W59842216","https://openalex.org/W2921477620","https://openalex.org/W2883616725","https://openalex.org/W7168295806","https://openalex.org/W137025916","https://openalex.org/W2068904330","https://openalex.org/W2128495947","https://openalex.org/W2048029383","https://openalex.org/W2010752185"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Substance":[1,185],"abuse":[2,107,122],"is":[3,25,30,72],"extremely":[4],"common":[5],"in":[6,56,66,74,108,225,246,260,284,322],"patients":[7,113,324],"with":[8,114,166,189,254,279,302],"bipolar":[9,115],"disorders,":[10,281],"although":[11],"minimal":[12],"data":[13],"are":[14,325],"available":[15],"on":[16,145,263],"the":[17,33,60,87,140,167,199,307],"treatment":[18,34,88,104],"of":[19,35,43,59,89,105,306],"this":[20],"important":[21],"clinical":[22],"population.":[23],"Aripiprazole":[24],"an":[26,129,317],"atypical":[27],"antipsychotic":[28],"that":[29,38],"approved":[31],"for":[32,86,103,171],"mania":[36],"and":[37,62,77,81,119,131,152,155,179,193,209,234,268,316],"has":[39],"a":[40,47,243,310],"novel":[41],"mechanism":[42],"action,":[44],"acting":[45],"as":[46],"dopamine-2":[48],"receptor":[49,96],"partial":[50,97],"agonist,":[51],"thereby":[52],"increasing":[53],"dopamine":[54],"release":[55,65,71],"some":[57],"parts":[58],"brain":[61,68],"decreasing":[63],"dopa-mine":[64,95],"other":[67],"regions.":[69],"Dopamine":[70],"implicated":[73],"substance":[75,90,106,121,153],"use,":[76,292],"both":[78],"dopaminergic":[79],"agonists":[80,98],"antagonists":[82],"have":[83,99],"been":[84,101],"examined":[85],"abuse.":[91],"To":[92],"our":[93],"knowledge,":[94],"not":[100,291],"investigated":[102],"humans.":[109],"METHOD:":[110],"Twenty":[111],"antipsychotic-treated":[112],"or":[116],"schizoaffective":[117],"disorder":[118],"current":[120,255],"were":[123,137,157,164,196,240,274,293],"switched":[124],"to":[125,218,298,327],"open-label":[126,318],"aripipra-zole":[127],"using":[128,139,198],"overlap":[130],"taper":[132],"method.":[133],"At":[134],"baseline,":[135],"diagnoses":[136],"confirmed":[138],"Mini-International":[141],"Neuropsychiatric":[142],"Interview":[143],"based":[144],"DSM-IV":[146],"criteria.":[147],"Psychiatric":[148,162,181],"symptoms,":[149],"side":[150,194,248],"effects,":[151],"use":[154],"craving":[156,186,270,286],"assessed":[158,165,188],"over":[159],"12":[160],"weeks.":[161],"symptoms":[163],"Hamilton":[168],"Rating":[169,176,182],"Scale":[170,177,183],"Depression":[172],"(HAM-D),":[173],"Young":[174],"Mania":[175],"(YMRS),":[178],"Brief":[180],"(BPRS).":[184],"was":[187,214,300],"visual":[190],"analogue":[191],"scales,":[192],"effects":[195],"monitored":[197],"Abnormal":[200],"Involuntary":[201],"Movement":[202],"Scale,":[203,205,208],"Simpson-Angus":[204],"Barnes":[206],"Akathisia":[207],"patient":[210],"report.":[211],"Study":[212],"enrollment":[213],"from":[215],"April":[216],"2003":[217],"February":[219],"2004.":[220],"RESULTS:":[221],"Significant":[222],"baseline-to-exit":[223],"improvement":[224],"HAM-D":[226],"(p":[227,231,236,265,271,287],"=":[228,232,237,266,272,288],".002),":[229],"YMRS":[230],".021),":[233],"BPRS":[235],".000)":[238],"scores":[239],"observed":[241],"without":[242],"significant":[244,258,282],"change":[245,297],"antipsychotic-induced":[247],"effect":[249],"scales.":[250],"In":[251,276],"17":[252],"participants":[253,278],"alcohol":[256,264,269],"dependence,":[257],"reductions":[259,283],"dollars":[261],"spent":[262],".042)":[267],".003)":[273],"found.":[275,294],"9":[277],"cocaine-related":[280],"cocaine":[285],".014),":[289],"but":[290],"CONCLUSION:":[295],"A":[296],"aripiprazole":[299],"associated":[301],"symptomatic":[303],"improvement.":[304],"Limitations":[305],"study":[308],"include":[309],"small":[311],"sample":[312],"size,":[313],"high":[314],"attrition,":[315],"design.":[319],"Controlled":[320],"trials":[321],"dual-diagnosis":[323],"needed":[326],"confirm":[328],"these":[329],"findings.":[330]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2004252407","counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
